AIDA v4 permits the effects of insulin dosage and dietary adjustments to be simulated for a typical patient's BG profile, with the working hypothesis being that patients, relatives, students and health-care professionals (HCPs) should be able to experience metabolic adjustments without risk of hypoglycaemia. The gene discussed is INS; the disease is Hypoglycemia.